Risultati della ricerca - Abhishek S. Kashyap
- Mostra 1 - 10 risultati su 10
-
1
Vitronectin—Master controller or micromanager? di David I. Leavesley, Abhishek S. Kashyap, Tristan I. Croll, Manaswini Sivaramakrishnan, Ali Shokoohmand, Brett G. Hollier, Zee Upton
Pubblicazione 2013Revisão -
2
Antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunity di Abhishek S. Kashyap, Tamara Thelemann, Richard Klar, Sandra M. Kallert, Julia Festag, Mélanie Buchi, Lisa Hinterwimmer, Monika Schell, Sven Michel, Frank Jaschinski, Alfred Zippelius
Pubblicazione 2019Artigo -
3
A molecular portrait of epithelial–mesenchymal plasticity in prostate cancer associated with clinical outcome di Nataly Stylianou, Melanie Lehman, Chenwei Wang, Atefeh Taherian Fard, Anja Rockstroh, Ladan Fazli, Lidija Jovanovic, Micheal Ward, Martin C. Sadowski, Abhishek S. Kashyap, Ralph Buttyan, Martin Gleave, Thomas F. Westbrook, Elizabeth D. Williams, Jennifer H. Gunter, Colleen C. Nelson, Brett G. Hollier
Pubblicazione 2018Artigo -
4
A novel anti-HER2 anthracycline-based antibody-drug conjugate induces adaptive anti-tumor immunity and potentiates PD-1 blockade in breast cancer di Lucia D’Amico, Ulrike Menzel, Michael Prummer, Philipp Müller, Mélanie Buchi, Abhishek S. Kashyap, Ulrike Haessler, Alexander Yermanos, Rémy Gébleux, Manfred Briendl, Tamara Hell, Fabian I. Wolter, Roger R. Beerli, Iva Truxová, Radek Špíšek, Tatjana Vlajnic, Ulf Grawunder, Sai T. Reddy, Alfred Zippelius
Pubblicazione 2019Artigo -
5
GEF-H1 Signaling upon Microtubule Destabilization Is Required for Dendritic Cell Activation and Specific Anti-tumor Responses di Abhishek S. Kashyap, Laura Fernández Rodríguez, Yun Zhao, Gianni Monaco, Marcel P. Trefny, Naohiro Yoshida, Kea Martin, Ashwani Sharma, Natacha Olieric, Pankaj R. Shah, Michal A. Stanczak, Nicole Kirchhammer, Sung‐Moo Park, Sébastien Wieckowski, Heinz Läubli, Rachid Zagani, Benjamin Kasenda, Michel O. Steinmetz, Hans-Christian Reinecker, Alfred Zippelius
Pubblicazione 2019Artigo -
6
Optimized antiangiogenic reprogramming of the tumor microenvironment potentiates CD40 immunotherapy di Abhishek S. Kashyap, Martina Schmittnaegel, Nicolò Rigamonti, Daniela Pais Ferreira, Philipp Mueller, Mélanie Buchi, Chia-Huey Ooi, Matthias Kreuzaler, Petra Hirschmann, Alan Guichard, Natascha Rieder, Ruben Bill, Frank Herting, Yvonne Kienast, Stefan Dirnhofer, Christian Klein, Sabine Hoves, Carola H. Ries, Emily Corse, Michele De Palma, Alfred Zippelius
Pubblicazione 2019Artigo -
7
NK cells with tissue-resident traits shape response to immunotherapy by inducing adaptive antitumor immunity di Nicole Kirchhammer, Marcel P. Trefny, Marina Natoli, Dominik Brücher, Sheena N. Smith, Franziska Werner, Victoria Koch, David Schreiner, Ewelina M. Bartoszek, Mélanie Buchi, Markus Schmid, Daniel Breu, K. Patricia Hartmann, Polina Zaytseva, Daniela S. Thommen, Heinz Läubli, Jan P. Böttcher, Michal A. Stanczak, Abhishek S. Kashyap, Andreas Plückthun, Alfred Zippelius
Pubblicazione 2022Artigo -
8
Fibroblast activation protein-targeted-4-1BB ligand agonist amplifies effector functions of intratumoral T cells in human cancer di Marta Trüb, Franziska Uhlenbrock, Christina Claus, Petra Herzig, Martin Thelen, Vaios Karanikas, Marina Bacac, Maria Amann, Rosemarie Albrecht, Claudia Ferrara, Daniela S. Thommen, Sacha Rothschield, Spasenija Savic Prince, Kirsten D. Mertz, Gieri Cathomas, Robert Rosenberg, Viola Heinzelmann‐Schwarz, Mark Wiese, Didier Lardinois, Pablo Umaña, Christian Klein, Heinz Läubli, Abhishek S. Kashyap, Alfred Zippelius
Pubblicazione 2020Artigo -
9
A Variant of a Killer Cell Immunoglobulin-like Receptor Is Associated with Resistance to PD-1 Blockade in Lung Cancer di Marcel P. Trefny, Sacha I. Rothschild, Franziska Uhlenbrock, Dietmar Rieder, Benjamin Kasenda, Michal A. Stanczak, Fiamma Berner, Abhishek S. Kashyap, Monika Kaiser, Petra Herzig, Severin Poechtrager, Daniela S. Thommen, Florian Geier, Spasenija Savic, Philip Jermann, Ilaria Alborelli, Stefan Schaub, Frank Stenner, Martin Früh, Zlatko Trajanoski, Lukas Flatz, Kirsten D. Mertz, Alfred Zippelius, Heinz Läubli
Pubblicazione 2019Artigo -
10
Targeting cancer glycosylation repolarizes tumor-associated macrophages allowing effective immune checkpoint blockade di Michal A. Stanczak, Natália Rodrigues Mantuano, Nicole Kirchhammer, David E. Sanin, Francis Jacob, Ricardo Coelho, Arun Everest‐Dass, Jinyu Wang, Marcel P. Trefny, Gianni Monaco, Anne Bärenwaldt, Melissa A. Gray, Adam Petrone, Abhishek S. Kashyap, Katharina Glatz, Benjamin Kasenda, Karl Normington, James Broderick, Peng Li, Oliver M.T. Pearce, Erika L. Pearce, Carolyn R. Bertozzi, Alfred Zippelius, Heinz Läubli
Pubblicazione 2022Artigo
Strumenti per la ricerca:
Soggetti correlati
Biology
Immunology
Cancer research
Immune system
Cancer
Immunotherapy
Receptor
Biochemistry
Blockade
Cell biology
Genetics
In vitro
Internal medicine
Medicine
Cancer immunotherapy
Chemistry
Cytotoxic T cell
T cell
Tumor microenvironment
Acquired immune system
Antibody
CD8
Dendritic cell
Immune checkpoint
Angiogenesis
Anthracycline
Bevacizumab
Breast cancer
CCL5
CD137